(Q38184614)

30 August 2017

title

Role of Toll-like receptors in diabetic nephropathy (English)

1 reference

30 August 2017

0 references

Harshini Mudaliar

1

1 reference

30 August 2017

Carol Pollock

series ordinal

2

1 reference

30 August 2017

Usha Panchapakesan

series ordinal

3

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 May 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

126

1 reference

30 August 2017

issue

10

1 reference

30 August 2017

page(s)

685-694

1 reference

Inflammation and diabetic nephropathy

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

RAAS inhibition and renal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Chronic kidney disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Inflammation and the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Role of inflammation in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Leukocyte recruitment and vascular injury in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Interaction between proximal tubular epithelial cells and infiltrating monocytes/T cells in the proteinuric state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Role of Toll-like receptors in liver health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptors in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

TLR4 links podocytes with the innate immune system to mediate glomerular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

How location governs toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Intracellular toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Endogenous ligands of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptors and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Crosstalk in NF-κB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptor 4 activates NF-κB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

The activation of NF-kappaB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Role of oxidative stress and inflammation in the origin of Type 2 diabetes--a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

PAMPs and DAMPs: signal 0s that spur autophagy and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Endogenous TLR ligands and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Endogenous ligands of TLR2 and TLR4: agonists or assistants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

HMGB1 contributes to kidney ischemia reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Role of AGEs in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemia-reperfusion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Increased expression of toll-like receptor 2 in rat diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptor 2 agonists inhibit human fibrocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Lipids and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

The role of Toll-like receptor pathways in the mechanism of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptors and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptor polymorphisms and susceptibility to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

In vitro inhibition of enterobacteria-reactive CD4+CD25- T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of strep

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Viral and nonviral uses of imiquimod: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Heat shock protein expression in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

The extra domain A of fibronectin activates Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Toll-like receptor 4 mediates oxidized LDL-induced macrophage differentiation to foam cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130267

21 January 2018

Identifiers

DOI

10.1042/CS20130267

1 reference

30 August 2017

1 reference